donislecel-jujn
Trade name: Lantidra
Cell therapyapprovedOrphan Drug FDA
Approved
Jun 28, 2023
Clinical trial activity
0 trials · 0 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
Indications
Approved for
Mechanism of action
- Pancreatic beta cellsTissue restoration
tissue restoration - pancreatic beta cells
Approval history
- approvedJun 28, 2023
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Organizations
Marketing (1)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Celltrans | Academic/Hospital | NDA | Jun 28, 2023 |